References
- Gerasimidis K, Barclay A, Papangelou A, et al. The epidemiology of anemia in pediatric inflammatory Bowel Disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm Bowel Dis. 2013;19:2411–2422.
- Wiskin AE, Fleming BJ, Wootton SA, et al. Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohn’s Colitis. 2012;6:687–691.
- Befrits R, Wikman O, Blomquist L, et al. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scand J Gastroenterol. 2013;48:1027–1032.
- Fernandes A, Bacalhau S Cabral J. Doença inflamatória intestinal pediátrica: uma patologia em crescendo? Acta Med Port. 2011;24(Suppl2):333–338.
- Goodhand JR, Kamperidis N, Rao A, et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:513–519.
- Danko I. Response of iron deficiency anemia to intravenous iron sucrose in pediatric inflammatory Bowel Disease. J Pediatr Pharmacol Ther. 2016;21:162–168.
- Koutroubakis IE, Ramos-Rivers C, Regueiro M, et al. Five-year period prevalence and characteristics of anemia in a large US inflammatory Bowel Disease cohort. J Clin Gastroenterol. 2016;50:638–643.
- Laass MW, Straub S, Chainey S, et al. Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC Gastroenterol. 2014;14:184.
- Valério de Azevedo S, Maltez C, Lopes AI. Pediatric Crohn’s disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Scand J Gastroenterol. 2016;52:29–33.
- Mantadakis E. Advances in pediatric intravenous iron therapy. Pediatr Blood Cancer. 2016;63:11–16.
- Gary R, Lichtenstein M. Highlights from the CCFA/advances in inflammatory Bowel diseases 2015 conference: commentary. Gastroenterol Hepatol. 2016;12.
- Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#. Inflamm Bowel Dis. 2007;13:1545–1553.
- Cronin CC Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol. 2001;96:2296–2298.
- Thayu M, Mamula P. Treatment of iron deficiency anemia in pediatric inflammatory bowel disease. Curr Treat Opt Gastroenterol. 2005;8:411–417.
- Danko I, Weidkamp M. Correction of iron deficiency anemia with intravenous iron sucrose in children with inflammatory Bowel disease. J Pediatr Gastroenterol Nutr. 2016;63:e107–e111.
- Powers JM, Shamoun M, McCavit TL, et al. Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron. J Pediatr. 2017;180:212–216.
- Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory Bowel Diseases. J Crohn’s Colitis. 2015;9:211–222.
- Auerbach M. Should intravenous iron be upfront therapy for iron deficiency anemia? Pediatr Blood Cancer. 2011;56:511–512.
- Ganzoni AM. Intravenous iron-dextran: Therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970;100:301–303.
- Ott C, Liebold A, Takses A, et al. High prevalence but insuffiient treatment of iron-deficiency anemia in patients with inflammatory Bowel disease: results of a population-based cohort. Gastroenterol Res Pract. 2012;2012:595970.
- Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276.
- Mamula P, Piccoli DA, Peck SN, et al. Total dose intravenous infusion of iron dextran for iron deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;34:286–290.